missing translation for 'onlineSavingsMsg'
Learn More

IL1RAPL1 Mouse anti-Human, Clone: B-R58, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-18111-200UL

 View more versions of this product

Product Code. 18331637

  • £324.00 / 200µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

IL1RAPL1 Monoclonal antibody specifically detects IL1RAPL1 in Human samples. It is validated for Flow Cytometry, ELISA
TRUSTED_SUSTAINABILITY
Specifications

Specifications

IL1RAPL1
Monoclonal
1 mg/ml
Flow Cytometry, ELISA
IL1R8IL1RAPL, IL-1-RAPL-1, IL-1RAPL-1, IL1RAPL-1, interleukin 1 receptor accessory protein-like 1, interleukin 1 receptor-8, interleukin-1 receptor accessory protein-like 1, mental retardation, X-linked 10, MRX10, MRX21, MRX34, Oligophrenin-4, OPHN4mental retardation, X-linked 21, Three immunoglobulin domain-containing IL-1 receptor-related 2, TIGIRR-2mental retardation, X-linked 34, X-linked interleukin-1 receptor accessory protein-like 1
Recombinant human IL1RAPL1. Hybridoma: Myeloma X63/AG.8653 x Balb/c spleen cells
200 μg
Primary
Human
Purified
Flow Cytometry, ELISA
B-R58
Unconjugated
PBS. Sterile-filtered through 0.22 um.
Mouse
Affinity purified
RUO
11141
Store at 4C short term. Aliquot and store at -70C long term. Avoid freeze-thaw cycles.
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.